Protalix BioTherapeutics Issues 2025 Letter to Stockholders ...Middle East

PR Newswire - News
Protalix BioTherapeutics Issues 2025 Letter to Stockholders

CARMIEL, Israel, Dec. 23, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE-American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell based protein...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Protalix BioTherapeutics Issues 2025 Letter to Stockholders )

    Apple Storegoogle play

    Also on site :